Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations.

Fujishiro H, Imamura AY, Lin WL, Uchikado H, Mark MH, Golbe LI, Markopoulou K, Wszolek ZK, Dickson DW.

Am J Neurodegener Dis. 2013 Nov 29;2(4):266-75.

Loss of DJ-1 protein stability and cytoprotective function by Parkinson's disease-associated proline-158 deletion.

Rannikko EH, Vesterager LB, Shaik JH, Weber SS, Cornejo Castro EM, Fog K, Jensen PH, Kahle PJ.

J Neurochem. 2013 Apr;125(2):314-27. doi: 10.1111/jnc.12126.

SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.

Li NN, Mao XY, Chang XL, Zhao DM, Zhang JH, Liao Q, Yu WJ, Tan EK, Peng R.

Am J Med Genet B Neuropsychiatr Genet. 2013 Jul;162B(5):452-6. doi: 10.1002/ajmg.b.32143.

Autoimmunity, dendritic cells and relevance for Parkinson's disease.

Koutsilieri E, Lutz MB, Scheller C.

J Neural Transm (Vienna). 2013 Jan;120(1):75-81. doi: 10.1007/s00702-012-0842-7. Review.

Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease.

Morales-García JA, Susín C, Alonso-Gil S, Pérez DI, Palomo V, Pérez C, Conde S, Santos A, Gil C, Martínez A, Pérez-Castillo A.

ACS Chem Neurosci. 2013 Feb 20;4(2):350-60. doi: 10.1021/cn300182g.

Rare variants in PLXNA4 and Parkinson's disease.

Schulte EC, Stahl I, Czamara D, Ellwanger DC, Eck S, Graf E, Mollenhauer B, Zimprich A, Lichtner P, Haubenberger D, Pirker W, Brücke T, Bereznai B, Molnar MJ, Peters A, Gieger C, Müller-Myhsok B, Tren

PLoS One. 2013 Nov 11;8(11):e79145. doi: 10.1371/journal.pone.0079145.

Implicit perceptual-motor skill learning in mild cognitive impairment and Parkinson's disease.

Gobel EW, Blomeke K, Zadikoff C, Simuni T, Weintraub S, Reber PJ.

Neuropsychology. 2013 May;27(3):314-21. doi: 10.1037/a0032305.

Pain in Parkinson disease: a review of the literature.

Fil A, Cano-de-la-Cuerda R, Muñoz-Hellín E, Vela L, Ramiro-González M, Fernández-de-Las-Peñas C.

Parkinsonism Relat Disord. 2013 Mar;19(3):285-94; discussion 285. doi: 10.1016/j.parkreldis.2012.11.009. Review.

Unraveling the mechanisms underlying postural instability in Parkinson's disease using dynamic posturography.

Nonnekes J, de Kam D, Geurts AC, Weerdesteyn V, Bloem BR.

Expert Rev Neurother. 2013 Dec;13(12):1303-8. doi: 10.1586/14737175.2013.839231. Review.

Subjectively impaired bed mobility in Parkinson disease affects sleep efficiency.

Louter M, van Sloun RJ, Pevernagie DA, Arends JB, Cluitmans PJ, Bloem BR, Overeem S.

Sleep Med. 2013 Jul;14(7):668-74. doi: 10.1016/j.sleep.2013.03.010.

Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease.

Navailles S, Lagière M, Roumegous A, Polito M, Boujema MB, Cador M, Dunlop J, Chesselet MF, Millan MJ, De Deurwaerdère P.

Int J Neuropsychopharmacol. 2013 Apr;16(3):593-606. doi: 10.1017/S1461145712000417.

Current amplitude-dependent modulation of rotational behavior with GPi stimulation in the rodent model of Parkinson's Disease.

Summerson SR, Kemere CT, Aazhang B.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:783-6. doi: 10.1109/EMBC.2013.6609617.

Sitting movement in elderly subjects with and without Parkinson's disease: a biomechanical study.

Dionisio VC, de Biagi Curtarelli M, Sande de Souza LA.

J Electromyogr Kinesiol. 2013 Aug;23(4):948-57. doi: 10.1016/j.jelekin.2013.03.005.

Rest energy expenditure in Parkinson's disease: role of disease progression and dopaminergic therapy.

Capecci M, Petrelli M, Emanuelli B, Millevolte M, Nicolai A, Provinciali L, Ceravolo MG.

Parkinsonism Relat Disord. 2013 Feb;19(2):238-41. doi: 10.1016/j.parkreldis.2012.10.016.

Discontinuities in slow finger movements in patients with Parkinson's disease.

Bettray LM, Eggers C, Quatuor EL, Florin E, Reck C, Pauls AK, Barbe MT, Fink GR, Timmermann L.

Neurosci Lett. 2013 Aug 26;548:10-4. doi: 10.1016/j.neulet.2013.02.068.